Dr. Manickam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6820 Hospital Dr
Suite 210
Baltimore, MD 21237Phone+1 410-391-6131Fax+1 410-391-6144
Education & Training
- Cleveland Clinic FloridaFellowship, Female Pelvic Medicine And Reconstructive Surgery (Urology), 2002 - 2003
- University of Illinois College of Medicine at ChicagoResidency, Urology, 1996 - 2002
- University of Illinois College of Medicine at ChicagoResidency, Surgery, 1996 - 1998
- University of Illinois College of MedicineClass of 1996
Certifications & Licensure
- MD State Medical License 2010 - 2025
- IN State Medical License 2002 - 2019
- IL State Medical License 1996 - 2017
- FL State Medical License 2002 - 2007
- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Professional EHR, Allscripts, 2013
Publications & Presentations
PubMed
- 2 citationsIsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study.Jason M Scovell, Mark Stovsky, Alan Partin, Yair Lotan, Jack Baniel
Urology. 2023-05-01 - 7 citationsClinical validation of IsoPSA, a single parameter, structure-focused assay for improved detection of prostate cancer: A prospective, multicenter study.Eric A Klein, Alan Partin, Yair Lotan, Jack Baniel, Martin Dineen
Urologic Oncology. 2022-09-01 - 13 citationsClinical Validation of IsoPSA™, a Single Parameter, Structure Based Assay for Improved Detection of High Grade Prostate Cancer.Mark Stovsky, Eric A. Klein, Arnon Chait, Kannan Manickam, Andrew J. Stephenson
The Journal of Urology. 2019-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: